Multiomic Health

MultiOmic Health is an AI-enabled precision medicine company focused on discovering and developing treatments for cardio-renal-metabolic (CRM) diseases, a group of chronic multifactorial conditions affecting over 2 billion patients worldwide. The company has built a platform combining deep longitudinal patient datasets, AI-driven data science, and experimental biology expertise to identify patient subpopulations with distinct molecular-level disease drivers, enabling targeted therapies and companion diagnostics. Its initial focus is chronic kidney disease (CKD), with plans to expand into broader cardiorenal and diabetic complications. MultiOmic Health is building a global CRM patient registry targeting over 100,000 patients by 2028.